CH 200 is a new antiarrhythmic drug. CH-200 suppressed arrhythmia in beagle dogs more effectively than did procainamide and lidocaine. The antiarrhythmic effects of CH-200 and procainamide developed slowly and lasted longer than those of lidocaine. References: Hashimoto K, Tsukada T, Matsuda H, Imai S. Antiarrhythmic and electrophysiological effects of CH-200. Eur J Pharmacol. 1977 Sep 15;45(2):185-94. PubMed PMID: 902689.

纯度：≥98%

CAS：64955-45-9